October 31, 2025

CorMedix Inc. (CRMD) Stock Analysis: A 67% Upside Potential with Strong Buy Ratings

CorMedix Inc. (CRMD), a biopharmaceutical company based in Berkeley Heights, New Jersey, is drawing significant attention from investors in the biotechnology sector. Specializing in the development and commercialization of therapeutic..

Cross Country Healthcare, Inc. (CCRN): Investor Outlook with a 53.80% Upside Potential

Cross Country Healthcare, Inc. (NASDAQ: CCRN) stands out in the healthcare sector, particularly within the medical care facilities industry. Headquartered in Boca Raton, Florida, the company specializes in providing essential..

Zenas BioPharma (ZBIO) Stock Analysis: Unpacking the 38.65% Potential Upside in the Biotech Space

Zenas BioPharma, Inc. (ZBIO) is capturing investor attention with its promising potential upside of 38.65%, according to recent analyst ratings. This clinical-stage biopharmaceutical company is making waves in the healthcare..

Claritev Corporation (CTEV): Investor Outlook Highlights 21% Potential Upside Amidst Growth in Healthcare Data Solutions

Investors looking for opportunities in the healthcare technology sector may find Claritev Corporation (NASDAQ: CTEV) an intriguing prospect. Specializing in data analytics and cost management solutions for the healthcare industry,..

Community Health Systems, Inc. (CYH): Investor Outlook on Healthcare Stock with Mixed Analyst Sentiment

Community Health Systems, Inc. (NYSE: CYH), a prominent player in the healthcare sector, operates an extensive network of medical facilities across the United States. Headquartered in Franklin, Tennessee, the company..

Xencor, Inc. (XNCR)

⚠️ No article content returned.

..

Altimmune, Inc. (ALT) Stock Analysis: A 304% Potential Upside Awaits Investors in the Biotech Arena

Altimmune, Inc. (ALT), a clinical-stage biopharmaceutical company, is grabbing investor attention with its promising pipeline and significant potential upside. Based in Gaithersburg, Maryland, Altimmune focuses on pioneering treatments for obesity,..

Mind Medicine (MindMed) Inc. (MNMD) Stock Analysis: Exploring an 86% Upside Potential with Analyst Confidence

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with an impressive market capitalization of $1.02 billion. Specializing in innovative treatments for..

Avadel Pharmaceuticals plc (AVDL) Stock Analysis: Navigating the Healthcare Sector’s Growth Potential

Avadel Pharmaceuticals plc (NASDAQ: AVDL) represents a compelling opportunity in the healthcare sector, especially within the specialty and generic drug manufacturing industry. With a market capitalization of $1.83 billion, this..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Uncovering a 36% Potential Upside in Biotech

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a trailblazer in the biotechnology sector, is capturing investor attention with its innovative approach to treating neurodegenerative diseases. With a market capitalization of $1.5 billion,..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Exploring the 231.72% Potential Upside

Investors eyeing the biotechnology sector for promising opportunities might want to take a closer look at Capricor Therapeutics, Inc. (NASDAQ: CAPR). With a market capitalization of $283.9 million, this U.S.-based..

Zevra Therapeutics, Inc. (ZVRA)

⚠️ No article content returned.

..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating a 8.46% Potential Upside in the Healthcare Sector

InnovAge Holding Corp. (NASDAQ: INNV), a healthcare company specializing in senior care through the Program of All-Inclusive Care for the Elderly (PACE), has been capturing investor attention with its unique..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: A Biotech Gamble with a 366% Potential Upside

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial-stage biopharmaceutical company, stands at the forefront of developing innovative cell therapies for treating metastatic melanoma and other solid tumor cancers. With its current..

LENZ Therapeutics, Inc. (LENZ)

⚠️ No article content returned.

..

Upstream Bio, Inc. (UPB) Stock Analysis: Unveiling a 93% Potential Upside in Biotech

In the dynamic world of biotechnology, Upstream Bio, Inc. (NASDAQ: UPB) emerges as a promising player with substantial growth prospects. With its robust 93.05% potential upside, the company has captured..

Keros Therapeutics, Inc. (KROS) Stock Analysis: Exploring a 53% Potential Upside in Biotechnology

Keros Therapeutics, Inc. (NASDAQ: KROS) stands as a promising player in the biotechnology sector, drawing attention with its innovative approach to treating disorders linked to dysfunctional signaling of the transforming..

Definitive Healthcare Corp. (DH) Stock Analysis: Navigating a 69.31% Potential Upside Amidst Challenges

Definitive Healthcare Corp. (NASDAQ: DH), a key player in the healthcare information services sector, is capturing investor attention with a notable potential upside of 69.31%. Despite facing several financial hurdles,..

HealthStream, Inc. (HSTM) Stock Analysis: Is a 38% Upside Within Reach?

HealthStream, Inc. (NASDAQ: HSTM) stands as a noteworthy contender in the Health Information Services industry, particularly for investors seeking exposure to the healthcare sector’s digital evolution. Headquartered in Nashville, Tennessee,..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Unpacking a 39.86% Potential Upside

Theravance Biopharma, Inc. (NASDAQ: TBPH), a prominent player in the biotechnology sector, has been drawing attention from investors due to its impressive potential upside and robust revenue growth. Based in..

Search

Funds

October 31, 2025

Search

Funds

October 31, 2025

FTSE 100

Funds